# Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

> **NCT00137462** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 900 (—)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** torcetrapib/atorvastatin
- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00137462
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 900 (—)
- **Last updated:** 2007-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137462, "Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00137462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
